Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials

Learning Objectives After completing this course, the reader will be able to: Discuss the implications of age bias in clinical trials. Describe the effects of applying clinical trial advances to the elderly as predicted by the available information. Explain the need for designing and implementing cl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2005-03, Vol.10 (3), p.198-204
Hauptverfasser:	Aapro, Matti S., Köhne, Claus‐Henning, Cohen, Harvey Jay, Extermann, Martine
Format:	Artikel
Sprache:	eng
Schlagworte:	5‐HT3‐receptor antagonists Age Factors Aged Bioethics Cancer Chemotherapy, Adjuvant Clinical trials Clinical Trials as Topic - ethics Elderly Eligibility Determination Ethics, Medical Evidence-Based Medicine Humans Neoplasms - therapy Palliative Care Practice Guidelines as Topic Radiotherapy, Adjuvant
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!